| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 4.19e-11 | 20 | 136 | 7 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 4.12e-09 | 36 | 136 | 7 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.11e-06 | 50 | 136 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.58e-06 | 53 | 136 | 6 | GO:0016859 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 MCF2 RCBTB2 OCRL CHRM4 PREX2 RGPD3 ARHGEF4 PREX1 AGAP1 RGPD5 | 1.97e-06 | 507 | 136 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 MCF2 RCBTB2 OCRL CHRM4 PREX2 RGPD3 ARHGEF4 PREX1 AGAP1 RGPD5 | 1.97e-06 | 507 | 136 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 OCRL PREX2 RGPD3 PREX1 AGAP1 RGPD5 | 3.38e-06 | 279 | 136 | 11 | GO:0005096 |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | RGPD4 UBR1 RGPD2 RANBP2 MED30 RGPD8 LONRF1 RGPD1 ZZEF1 RGPD3 CCAR1 TRIM60 | 1.83e-05 | 398 | 136 | 12 | GO:0061659 |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | RGPD4 UBR1 RGPD2 RANBP2 MED30 RGPD8 LONRF1 RGPD1 ZZEF1 RGPD3 CCAR1 TRIM60 | 2.02e-04 | 512 | 136 | 12 | GO:0019787 |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 2.34e-04 | 18 | 136 | 3 | GO:0042809 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | RGPD4 UBR1 RGPD2 RANBP2 MED30 RGPD8 LONRF1 RGPD1 ZZEF1 RGPD3 CCAR1 TRIM60 | 2.87e-04 | 532 | 136 | 12 | GO:0016755 |
| GeneOntologyMolecularFunction | isomerase activity | 3.50e-04 | 192 | 136 | 7 | GO:0016853 | |
| GeneOntologyMolecularFunction | small GTPase binding | 3.60e-04 | 321 | 136 | 9 | GO:0031267 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 7.95e-04 | 61 | 136 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | GTPase binding | 8.19e-04 | 360 | 136 | 9 | GO:0051020 | |
| GeneOntologyMolecularFunction | acyltransferase activity | RGPD4 UBR1 RGPD2 RANBP2 MED30 RGPD8 LONRF1 RGPD1 HAT1 ZZEF1 RGPD3 MSL3 CCAR1 TRIM60 | 8.36e-04 | 775 | 136 | 14 | GO:0016746 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 1.58e-03 | 34 | 136 | 3 | GO:0050750 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 1.58e-03 | 34 | 136 | 3 | GO:0046966 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 OCRL EPGN PREX2 RGPD3 PREX1 AGAP1 RGPD5 | 1.78e-03 | 656 | 136 | 12 | GO:0008047 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 6.35e-12 | 9 | 137 | 6 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.58e-11 | 10 | 137 | 6 | GO:1903301 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 3.52e-11 | 20 | 137 | 7 | GO:0006607 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.27e-10 | 13 | 137 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 2.21e-10 | 14 | 137 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.78e-07 | 38 | 137 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 1.53e-06 | 54 | 137 | 6 | GO:0018208 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.94e-06 | 217 | 137 | 10 | GO:0006403 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 3.01e-06 | 178 | 137 | 9 | GO:0051236 | |
| GeneOntologyBiologicalProcess | mRNA transport | 5.72e-06 | 145 | 137 | 8 | GO:0051028 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 7.73e-06 | 71 | 137 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | RNA transport | 2.26e-05 | 175 | 137 | 8 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 2.26e-05 | 175 | 137 | 8 | GO:0050657 | |
| GeneOntologyBiologicalProcess | nuclear export | 3.36e-05 | 185 | 137 | 8 | GO:0051168 | |
| GeneOntologyBiologicalProcess | protein folding | RGPD4 DNAJB12 RGPD2 RANBP2 HSP90B2P RGPD8 RGPD1 DNAJC18 RGPD3 | 4.02e-05 | 246 | 137 | 9 | GO:0006457 |
| GeneOntologyBiologicalProcess | gluconeogenesis | 9.84e-05 | 111 | 137 | 6 | GO:0006094 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 1.20e-04 | 115 | 137 | 6 | GO:0019319 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 1.58e-04 | 121 | 137 | 6 | GO:0046364 | |
| GeneOntologyBiologicalProcess | somatic hypermutation of immunoglobulin genes | 1.82e-04 | 17 | 137 | 3 | GO:0016446 | |
| GeneOntologyBiologicalProcess | somatic diversification of immune receptors via somatic mutation | 2.17e-04 | 18 | 137 | 3 | GO:0002566 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 2.54e-04 | 132 | 137 | 6 | GO:0043255 | |
| GeneOntologyBiologicalProcess | immune system development | 2.57e-04 | 248 | 137 | 8 | GO:0002520 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 2.64e-04 | 249 | 137 | 8 | GO:0015931 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 2.75e-04 | 134 | 137 | 6 | GO:0010906 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 3.31e-04 | 195 | 137 | 7 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 3.97e-04 | 201 | 137 | 7 | GO:0051170 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-3-phosphate biosynthetic process | 4.02e-04 | 22 | 137 | 3 | GO:0036092 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.97e-12 | 8 | 137 | 6 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.46e-11 | 10 | 137 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 2.04e-10 | 14 | 137 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.23e-09 | 18 | 137 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 2.55e-09 | 20 | 137 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 3.55e-09 | 21 | 137 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear pore | 3.35e-07 | 101 | 137 | 8 | GO:0005643 | |
| GeneOntologyCellularComponent | inclusion body | 2.81e-05 | 90 | 137 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 RGPD2 RANBP2 MED30 RGPD8 MYO1C VPS4A MIS18A RGPD1 MAGOHB MSH2 ELL3 RXRA NUFIP1 RGPD3 BUD31 SLC5A8 ANAPC5 UTY MED13 SMG6 RGPD5 RBM17 | 3.01e-05 | 1377 | 137 | 23 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 DNAJB12 RGPD2 RANBP2 RGPD8 VPS4A RGPD1 PTGER3 RGPD3 CCAR1 SCAI RGPD5 | 3.24e-04 | 560 | 137 | 12 | GO:0005635 |
| GeneOntologyCellularComponent | nuclear membrane | 5.01e-04 | 349 | 137 | 9 | GO:0031965 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex, eIF3m | 1.49e-03 | 9 | 137 | 2 | GO:0071541 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 9.82e-10 | 16 | 102 | 6 | MP:0003701 | |
| MousePheno | increased sarcoma incidence | 3.34e-09 | 102 | 102 | 10 | MP:0002032 | |
| MousePheno | abnormal tumor latency | 4.09e-09 | 34 | 102 | 7 | MP:0010307 | |
| MousePheno | increased hepatobiliary system tumor incidence | 7.64e-09 | 111 | 102 | 10 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 7.64e-09 | 111 | 102 | 10 | MP:0008019 | |
| MousePheno | abnormal morula morphology | 2.66e-08 | 26 | 102 | 6 | MP:0012058 | |
| MousePheno | decreased tumor latency | 6.70e-08 | 30 | 102 | 6 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 8.26e-08 | 31 | 102 | 6 | MP:0012129 | |
| MousePheno | abnormal blastocyst formation | 3.49e-07 | 39 | 102 | 6 | MP:0012128 | |
| MousePheno | abnormal mitosis | 3.81e-07 | 128 | 102 | 9 | MP:0004046 | |
| MousePheno | increased hepatocellular carcinoma incidence | 7.36e-07 | 70 | 102 | 7 | MP:0003331 | |
| MousePheno | increased respiratory system tumor incidence | 1.09e-06 | 107 | 102 | 8 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 1.09e-06 | 107 | 102 | 8 | MP:0008014 | |
| MousePheno | increased malignant tumor incidence | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 HAT1 RCBTB2 MSH2 TGFBI RGPD3 ATM | 1.21e-06 | 237 | 102 | 11 | MP:0002018 |
| MousePheno | increased lung carcinoma incidence | 1.55e-06 | 78 | 102 | 7 | MP:0008714 | |
| MousePheno | abnormal chromosome morphology | 3.76e-06 | 126 | 102 | 8 | MP:0003702 | |
| MousePheno | aneuploidy | 5.22e-06 | 61 | 102 | 6 | MP:0004024 | |
| MousePheno | abnormal cell nucleus morphology | 7.80e-06 | 184 | 102 | 9 | MP:0003111 | |
| MousePheno | increased incidence of tumors by chemical induction | 8.67e-06 | 141 | 102 | 8 | MP:0004499 | |
| MousePheno | abnormal intracellular organelle morphology | RGPD4 RGPD2 RANBP2 MED30 RPL38 RGPD8 RGPD1 HAT1 LANCL1 ADGRG6 TGFBI RGPD3 ABCD3 ZFYVE26 ATM | 9.37e-06 | 546 | 102 | 15 | MP:0014239 |
| MousePheno | belly spot | 1.14e-05 | 41 | 102 | 5 | MP:0000373 | |
| MousePheno | increased carcinoma incidence | 1.35e-05 | 197 | 102 | 9 | MP:0002038 | |
| MousePheno | increased classified tumor incidence | RGPD4 RGPD2 RANBP2 RGPD8 ESR2 RGPD1 HAT1 RCBTB2 MSH2 TGFBI RGPD3 ATM | 2.10e-05 | 381 | 102 | 12 | MP:0010273 |
| MousePheno | abnormal classified tumor incidence | RGPD4 RGPD2 RANBP2 RGPD8 ESR2 RGPD1 HAT1 RCBTB2 MSH2 TGFBI RGPD3 ATM | 2.26e-05 | 384 | 102 | 12 | MP:0020188 |
| MousePheno | abnormal rod electrophysiology | 2.57e-05 | 119 | 102 | 7 | MP:0004021 | |
| MousePheno | increased organ/body region tumor incidence | RGPD4 RGPD2 RANBP2 RGPD8 ESR2 RGPD1 HAT1 RCBTB2 MSH2 TGFBI RGPD3 ATM | 2.99e-05 | 395 | 102 | 12 | MP:0010274 |
| MousePheno | white spotting | 3.06e-05 | 50 | 102 | 5 | MP:0002938 | |
| MousePheno | abnormal organ/body region tumor incidence | RGPD4 RGPD2 RANBP2 RGPD8 ESR2 RGPD1 HAT1 RCBTB2 MSH2 TGFBI RGPD3 ATM | 3.46e-05 | 401 | 102 | 12 | MP:0013152 |
| MousePheno | abnormal chromosome number | 3.82e-05 | 86 | 102 | 6 | MP:0004023 | |
| MousePheno | increased incidence of induced tumors | 3.82e-05 | 173 | 102 | 8 | MP:0002021 | |
| MousePheno | enlarged epididymis | 8.43e-05 | 99 | 102 | 6 | MP:0004931 | |
| MousePheno | abnormal cell cycle | RGPD4 RGPD2 RANBP2 RGPD8 MIS18A RGPD1 HAT1 RGPD3 ASPM PKHD1 ATM SMC1B SCAI | 1.02e-04 | 520 | 102 | 13 | MP:0003077 |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 1.30e-04 | 107 | 102 | 6 | MP:0003694 | |
| MousePheno | abnormal incidence of induced tumors | 1.52e-04 | 269 | 102 | 9 | MP:0013151 | |
| MousePheno | abnormal epididymis morphology | 1.52e-04 | 269 | 102 | 9 | MP:0002631 | |
| MousePheno | abnormal blastocyst hatching | 1.75e-04 | 113 | 102 | 6 | MP:0003693 | |
| MousePheno | abnormal epididymis size | 2.10e-04 | 166 | 102 | 7 | MP:0004926 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 2.41e-04 | 286 | 102 | 9 | MP:0008873 | |
| MousePheno | abnormal preimplantation embryo development | 2.52e-04 | 171 | 102 | 7 | MP:0009781 | |
| MousePheno | abnormal physiological response to xenobiotic | RGPD4 RGPD2 RANBP2 RGPD8 ESR2 RGPD1 LANCL1 DNAJC27 MSH2 ACE PTGER3 TGFBI RGPD3 PLA2G5 | 3.11e-04 | 662 | 102 | 14 | MP:0008872 |
| MousePheno | neoplasm | RGPD4 RGPD2 RANBP2 RGPD8 ESR2 RGPD1 HAT1 DNAJC27 RCBTB2 MSH2 ACE TGFBI RGPD3 ATM ARHGEF4 | 3.26e-04 | 747 | 102 | 15 | MP:0002006 |
| MousePheno | increased tumor incidence | RGPD4 RGPD2 RANBP2 RGPD8 ESR2 RGPD1 HAT1 RCBTB2 MSH2 TGFBI RGPD3 ATM | 4.71e-04 | 530 | 102 | 12 | MP:0002020 |
| MousePheno | abnormal hallux morphology | 5.20e-04 | 5 | 102 | 2 | MP:0009049 | |
| MousePheno | abnormal tumor incidence | RGPD4 RGPD2 RANBP2 RGPD8 ESR2 RGPD1 HAT1 DNAJC27 RCBTB2 MSH2 TGFBI RGPD3 ATM | 7.02e-04 | 635 | 102 | 13 | MP:0002019 |
| MousePheno | persistent hyperplastic primary vitreous | 7.76e-04 | 6 | 102 | 2 | MP:0010711 | |
| MousePheno | complete atrioventricular septal defect | 8.68e-04 | 26 | 102 | 3 | MP:0010413 | |
| MousePheno | abnormal tumor susceptibility | RGPD4 RGPD2 RANBP2 RGPD8 ESR2 RGPD1 HAT1 DNAJC27 RCBTB2 MSH2 TGFBI RGPD3 ATM | 8.71e-04 | 650 | 102 | 13 | MP:0002166 |
| Domain | Ran_BP1 | 6.42e-13 | 12 | 134 | 7 | PF00638 | |
| Domain | RANBD1 | 6.42e-13 | 12 | 134 | 7 | PS50196 | |
| Domain | RanBD | 1.38e-12 | 13 | 134 | 7 | SM00160 | |
| Domain | Ran_bind_dom | 1.38e-12 | 13 | 134 | 7 | IPR000156 | |
| Domain | Grip | 5.47e-11 | 11 | 134 | 6 | SM00755 | |
| Domain | GRIP | 5.47e-11 | 11 | 134 | 6 | PF01465 | |
| Domain | GRIP_dom | 1.09e-10 | 12 | 134 | 6 | IPR000237 | |
| Domain | GRIP | 1.09e-10 | 12 | 134 | 6 | PS50913 | |
| Domain | Rab_bind | 3.66e-10 | 7 | 134 | 5 | PF16704 | |
| Domain | GCC2_Rab_bind | 3.66e-10 | 7 | 134 | 5 | IPR032023 | |
| Domain | TPR-like_helical_dom | RGPD4 RGPD2 SH3TC2 RANBP2 RGPD8 LONRF1 IFT172 RGPD1 RMDN3 RGPD3 ANAPC5 UTY SMG6 RGPD5 | 1.36e-09 | 233 | 134 | 14 | IPR011990 |
| Domain | TPR_REGION | RGPD4 RGPD2 SH3TC2 RANBP2 RGPD8 LONRF1 IFT172 RGPD1 RGPD3 ANAPC5 UTY RGPD5 | 2.51e-09 | 165 | 134 | 12 | PS50293 |
| Domain | TPR | RGPD4 RGPD2 SH3TC2 RANBP2 RGPD8 LONRF1 IFT172 RGPD1 RGPD3 ANAPC5 UTY RGPD5 | 2.51e-09 | 165 | 134 | 12 | PS50005 |
| Domain | - | 4.32e-09 | 10 | 134 | 5 | 1.10.220.60 | |
| Domain | TPR-contain_dom | RGPD4 RGPD2 SH3TC2 RANBP2 RGPD8 LONRF1 RGPD1 RGPD3 ANAPC5 UTY RGPD5 | 1.09e-08 | 150 | 134 | 11 | IPR013026 |
| Domain | TPR | RGPD4 RGPD2 SH3TC2 RANBP2 RGPD8 LONRF1 RGPD1 RGPD3 ANAPC5 UTY | 3.07e-08 | 129 | 134 | 10 | SM00028 |
| Domain | - | RGPD4 RGPD2 SH3TC2 RANBP2 RGPD8 LONRF1 RGPD1 RMDN3 RGPD3 ANAPC5 UTY SMG6 | 3.22e-08 | 207 | 134 | 12 | 1.25.40.10 |
| Domain | TPR_repeat | RGPD4 RGPD2 SH3TC2 RANBP2 RGPD8 LONRF1 RGPD1 RGPD3 ANAPC5 UTY | 4.11e-08 | 133 | 134 | 10 | IPR019734 |
| Domain | PH_dom-like | RGPD4 RGPD2 RANBP2 RGPD8 MYO10 RGPD1 MCF2 PREX2 RTKN2 RGPD3 ARHGEF4 PREX1 AGAP1 RGPD5 | 2.37e-06 | 426 | 134 | 14 | IPR011993 |
| Domain | - | RGPD4 RGPD2 RANBP2 RGPD8 MYO10 RGPD1 MCF2 PREX2 RTKN2 RGPD3 ARHGEF4 PREX1 AGAP1 | 4.88e-06 | 391 | 134 | 13 | 2.30.29.30 |
| Domain | TPR_1 | 4.63e-05 | 90 | 134 | 6 | IPR001440 | |
| Domain | TPR_1 | 4.63e-05 | 90 | 134 | 6 | PF00515 | |
| Domain | EIF3C_N_dom | 5.11e-05 | 2 | 134 | 2 | IPR008905 | |
| Domain | eIF-3c_N | 5.11e-05 | 2 | 134 | 2 | PF05470 | |
| Domain | EIF3C | 5.11e-05 | 2 | 134 | 2 | IPR027516 | |
| Domain | DUF1977 | 1.53e-04 | 3 | 134 | 2 | PF09320 | |
| Domain | DUF1977_DnaJ-like | 1.53e-04 | 3 | 134 | 2 | IPR015399 | |
| Domain | GDS_CDC24_CS | 1.71e-04 | 39 | 134 | 4 | IPR001331 | |
| Domain | Anoct_dimer | 1.05e-03 | 7 | 134 | 2 | PF16178 | |
| Domain | Anoct_dimer | 1.05e-03 | 7 | 134 | 2 | IPR032394 | |
| Domain | DH_1 | 1.09e-03 | 63 | 134 | 4 | PS00741 | |
| Domain | P-loop_NTPase | MYO1C MYO10 VPS4A BMS1 DNAJC27 MSH2 PFKFB2 GTPBP10 SBNO2 TK1 ASPM ABCD3 DNAH5 SMC1B AGAP1 | 1.13e-03 | 848 | 134 | 15 | IPR027417 |
| Domain | PH | 1.34e-03 | 229 | 134 | 7 | PF00169 | |
| Domain | RhoGEF | 1.45e-03 | 68 | 134 | 4 | SM00325 | |
| Domain | RhoGEF | 1.61e-03 | 70 | 134 | 4 | PF00621 | |
| Domain | DH_2 | 1.61e-03 | 70 | 134 | 4 | PS50010 | |
| Domain | - | 1.70e-03 | 71 | 134 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 1.70e-03 | 71 | 134 | 4 | IPR000219 | |
| Domain | Anoctamin | 2.21e-03 | 10 | 134 | 2 | PF04547 | |
| Domain | Anoctamin | 2.21e-03 | 10 | 134 | 2 | IPR007632 | |
| Domain | PH | 3.96e-03 | 278 | 134 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 4.04e-03 | 279 | 134 | 7 | PS50003 | |
| Domain | PH_domain | 4.12e-03 | 280 | 134 | 7 | IPR001849 | |
| Domain | DnaJ | 4.93e-03 | 48 | 134 | 3 | PF00226 | |
| Domain | PI3/4_kinase_CS | 5.05e-03 | 15 | 134 | 2 | IPR018936 | |
| Domain | DNAJ_1 | 5.23e-03 | 49 | 134 | 3 | PS00636 | |
| Domain | DNAJ_2 | 5.23e-03 | 49 | 134 | 3 | PS50076 | |
| Domain | DnaJ | 5.23e-03 | 49 | 134 | 3 | SM00271 | |
| Domain | - | 5.23e-03 | 49 | 134 | 3 | 1.10.287.110 | |
| Domain | - | 5.74e-03 | 16 | 134 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 5.74e-03 | 16 | 134 | 2 | SM00146 | |
| Domain | PINT | 5.74e-03 | 16 | 134 | 2 | SM00088 | |
| Domain | DnaJ_domain | 5.85e-03 | 51 | 134 | 3 | IPR001623 | |
| Domain | PCI_dom | 6.48e-03 | 17 | 134 | 2 | IPR000717 | |
| Domain | PCI | 6.48e-03 | 17 | 134 | 2 | PF01399 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.68e-09 | 18 | 98 | 6 | MM1549 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.07e-07 | 40 | 98 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 3.57e-07 | 41 | 98 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 4.14e-07 | 42 | 98 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 4.79e-07 | 43 | 98 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 8.25e-07 | 47 | 98 | 6 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.06e-06 | 49 | 98 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.20e-06 | 50 | 98 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.35e-06 | 51 | 98 | 6 | MM15151 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.57e-06 | 82 | 98 | 7 | MM15394 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.13e-06 | 55 | 98 | 6 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.92e-06 | 58 | 98 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.92e-06 | 58 | 98 | 6 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 5.74e-06 | 65 | 98 | 6 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.13e-05 | 73 | 98 | 6 | MM14948 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 1.68e-05 | 117 | 98 | 7 | MM15387 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 2.54e-05 | 84 | 98 | 6 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 2.90e-05 | 86 | 98 | 6 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 4.26e-05 | 92 | 98 | 6 | MM14951 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 5.59e-05 | 141 | 98 | 7 | MM15266 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 6.81e-05 | 100 | 98 | 6 | MM14561 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.41e-04 | 114 | 98 | 6 | MM15361 | |
| Pathway | REACTOME_SUMOYLATION | 1.74e-04 | 169 | 98 | 7 | MM14919 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 2.23e-04 | 234 | 98 | 8 | MM14898 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.76e-04 | 129 | 98 | 6 | MM14894 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 3.91e-04 | 193 | 98 | 7 | MM14890 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 5.94e-04 | 271 | 98 | 8 | MM15388 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 6.86e-04 | 277 | 98 | 8 | MM15414 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | RGPD4 RGPD2 RANBP2 RGPD8 MINK1 RGPD1 APOB RXRA RGPD3 ATM ANAPC5 | 7.51e-04 | 505 | 98 | 11 | MM15548 |
| Pathway | REACTOME_CELL_CYCLE | RGPD4 RGPD2 RANBP2 RGPD8 VPS4A MIS18A RGPD1 SHQ1 FBXL7 RGPD3 ATM ANAPC5 | 9.47e-04 | 603 | 98 | 12 | MM14635 |
| Pathway | REACTOME_METABOLISM_OF_RNA | RGPD4 RGPD2 RANBP2 RPL38 RGPD8 BMS1 RGPD1 RGPD3 BUD31 UTP20 SMG6 RBM17 | 1.08e-03 | 612 | 98 | 12 | MM15547 |
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 2.44e-14 | 7 | 138 | 6 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 2.44e-14 | 7 | 138 | 6 | 11353387 | |
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 30944974 | ||
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 2.44e-14 | 7 | 138 | 6 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 2.44e-14 | 7 | 138 | 6 | 17372272 | |
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 38657106 | ||
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 21205196 | ||
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 18949001 | ||
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 25187515 | ||
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 8603673 | ||
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 26632511 | ||
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 24403063 | ||
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 23818861 | ||
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 23536549 | ||
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 12191015 | ||
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 22821000 | ||
| Pubmed | 2.44e-14 | 7 | 138 | 6 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 9.73e-14 | 8 | 138 | 6 | 21670213 | |
| Pubmed | 9.73e-14 | 8 | 138 | 6 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 9.73e-14 | 8 | 138 | 6 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 9.73e-14 | 8 | 138 | 6 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 9.73e-14 | 8 | 138 | 6 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 2.91e-13 | 9 | 138 | 6 | 18394993 | |
| Pubmed | 2.91e-13 | 9 | 138 | 6 | 28100513 | ||
| Pubmed | 2.91e-13 | 9 | 138 | 6 | 17887960 | ||
| Pubmed | 2.91e-13 | 9 | 138 | 6 | 11553612 | ||
| Pubmed | 2.91e-13 | 9 | 138 | 6 | 10601307 | ||
| Pubmed | 2.91e-13 | 9 | 138 | 6 | 9733766 | ||
| Pubmed | 2.91e-13 | 9 | 138 | 6 | 28877029 | ||
| Pubmed | 7.25e-13 | 10 | 138 | 6 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 7.25e-13 | 10 | 138 | 6 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 7.25e-13 | 10 | 138 | 6 | 8857542 | |
| Pubmed | 7.25e-13 | 10 | 138 | 6 | 21859863 | ||
| Pubmed | 1.59e-12 | 11 | 138 | 6 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.59e-12 | 11 | 138 | 6 | 35771867 | |
| Pubmed | 1.59e-12 | 11 | 138 | 6 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 5.87e-12 | 13 | 138 | 6 | 31427429 | |
| Pubmed | 1.70e-11 | 15 | 138 | 6 | 14697343 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 MSH2 SBNO2 EIF3CL RGPD3 EIF3C ANAPC5 | 2.96e-11 | 153 | 138 | 11 | 26365490 |
| Pubmed | 2.48e-10 | 22 | 138 | 6 | 27717094 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 8.70e-09 | 38 | 138 | 6 | 12791264 | |
| Pubmed | 1.46e-07 | 99 | 138 | 7 | 27746211 | ||
| Pubmed | 2.14e-07 | 215 | 138 | 9 | 35973513 | ||
| Pubmed | 2.44e-07 | 4 | 138 | 3 | 9480752 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 RGPD2 RANBP2 RGPD8 RGPD1 EIF3CL NUFIP1 RMDN3 RTKN2 RGPD3 MSL3 ASPM CCAR1 EIF3C ATM ANAPC5 RGPD5 RBM17 | 7.98e-07 | 1155 | 138 | 18 | 20360068 |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 1.21e-06 | 135 | 138 | 7 | 31077711 | |
| Pubmed | 1.21e-06 | 6 | 138 | 3 | 24097111 | ||
| Pubmed | 1.27e-06 | 86 | 138 | 6 | 37253089 | ||
| Pubmed | DNAJB12 RANBP2 RPL38 RHBDF1 MINK1 BMS1 GTPBP10 RMDN3 STX18 ACAD11 RGPD3 ABCD3 CCAR1 UTP20 EIF3C ANAPC5 PREX1 MED13 AGAP1 SMG6 | 2.00e-06 | 1497 | 138 | 20 | 31527615 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 2.04e-06 | 146 | 138 | 7 | 23892456 | |
| Pubmed | RGPD4 RGPD2 RANBP2 RPL38 RGPD8 RGPD1 ZDBF2 ZNF462 RGPD3 ABCD3 | 7.12e-06 | 418 | 138 | 10 | 34709266 | |
| Pubmed | RGPD4 RGPD2 RANBP2 RPL38 RGPD8 MYO1C RGPD1 MAGOHB LANCL1 ME2 EIF3CL RGPD3 EIF3C RGPD5 | 7.23e-06 | 844 | 138 | 14 | 25963833 | |
| Pubmed | 7.26e-06 | 116 | 138 | 6 | 30652415 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 DNAJB12 RGPD2 RANBP2 RPL38 RGPD8 MYO1C VPS4A RGPD1 HAT1 SAMHD1 MSH2 EIF3CL RGPD3 ABCD3 EIF3C RGPD5 | 1.07e-05 | 1257 | 138 | 17 | 37317656 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 RANBP2 MYO1C MINK1 ISL2 EIF3CL MSL3 CCAR1 UTP20 EIF3C ATM ANAPC5 MED13 | 1.37e-05 | 774 | 138 | 13 | 15302935 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RANBP2 RPL38 MYO1C VPS4A BMS1 HAT1 LANCL1 APOB SAMHD1 MSH2 ME2 EIF3CL ABCD3 CCAR1 UTP20 EIF3C ATM DNAH5 | 1.46e-05 | 1425 | 138 | 18 | 30948266 |
| Pubmed | Individual substitution mutations in the AID C terminus that ablate IgH class switch recombination. | 1.56e-05 | 2 | 138 | 2 | 26267846 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27261510 | ||
| Pubmed | Combined deficiency of MSH2 and Sμ region abolishes class switch recombination. | 1.56e-05 | 2 | 138 | 2 | 20812239 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20694145 | ||
| Pubmed | EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis. | 1.56e-05 | 2 | 138 | 2 | 36157221 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 16862188 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 29846435 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 16061639 | ||
| Pubmed | P-Rex2 regulates Purkinje cell dendrite morphology and motor coordination. | 1.56e-05 | 2 | 138 | 2 | 18334636 | |
| Pubmed | SAMHD1 enhances immunoglobulin hypermutation by promoting transversion mutation. | 1.56e-05 | 2 | 138 | 2 | 29669924 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 28710285 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24080207 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27466510 | ||
| Pubmed | The mismatch repair pathway functions normally at a non-AID target in germinal center B cells. | 1.56e-05 | 2 | 138 | 2 | 21788338 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22041135 | ||
| Pubmed | The ER-Mitochondria Tethering Complex VAPB-PTPIP51 Regulates Autophagy. | 1.56e-05 | 2 | 138 | 2 | 28132811 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | DNAJB12 AMPD2 RANBP2 VPS4A DNAJC18 HAT1 SAMHD1 MSH2 OCRL RMDN3 STX18 ABCD3 UTP20 ANAPC5 | 2.45e-05 | 942 | 138 | 14 | 31073040 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RANBP2 HAT1 SAMHD1 MSH2 STX18 TK1 RGPD3 ABCD3 CCAR1 UTP20 EIF3C DNAH5 | 2.58e-05 | 704 | 138 | 12 | 29955894 |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 3.51e-05 | 226 | 138 | 7 | 37839992 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RHBDF1 MYO10 LONRF1 ZZEF1 CHRM4 SBNO2 DIP2A PIK3C2B USP40 PCNX1 ZFYVE26 ARHGEF4 PREX1 MED13 SMG6 | 3.52e-05 | 1105 | 138 | 15 | 35748872 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 4.04e-05 | 231 | 138 | 7 | 16452087 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 4.04e-05 | 231 | 138 | 7 | 36597993 | |
| Pubmed | RGPD8 IFT172 HAT1 APOB PFKFB2 ZNF462 RGPD3 ADAMTS20 SMG6 RBM17 | 4.10e-05 | 513 | 138 | 10 | 25798074 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 31757865 | ||
| Pubmed | Uracil residues dependent on the deaminase AID in immunoglobulin gene variable and switch regions. | 4.68e-05 | 3 | 138 | 2 | 21151102 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 15223114 | ||
| Pubmed | Two levels of protection for the B cell genome during somatic hypermutation. | 4.68e-05 | 3 | 138 | 2 | 18273020 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 26400962 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 30946744 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 35222362 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 16894013 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 22768095 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 26088318 | ||
| Pubmed | Repair genes expression profile of MLH1, MSH2 and ATM in the normal oral mucosa of chronic smokers. | 4.68e-05 | 3 | 138 | 2 | 27693945 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 11359065 | ||
| Pubmed | Five polymorphisms in gene candidates for cardiovascular disease in Afro-Brazilian individuals. | 4.68e-05 | 3 | 138 | 2 | 15543563 | |
| Pubmed | Requirement of non-canonical activity of uracil DNA glycosylase for class switch recombination. | 4.68e-05 | 3 | 138 | 2 | 17090531 | |
| Pubmed | Transcription factor TLX1 controls retinoic acid signaling to ensure spleen development. | 4.77e-05 | 18 | 138 | 3 | 27214556 | |
| Pubmed | LONRF1 IFT172 ZNF423 CLIC6 NUFIP1 DIP2A STX18 SULF1 CCAR1 EIF3C ATM MGAT5B PREX1 MED13 SCAI AGAP1 | 5.35e-05 | 1285 | 138 | 16 | 35914814 | |
| Pubmed | UBR1 MINK1 LANCL1 ZZEF1 SBNO2 TGFBI DIP2A ACAD11 ABCD3 CCAR1 ANAPC5 | 6.03e-05 | 650 | 138 | 11 | 38777146 | |
| Pubmed | RGPD4 RGPD2 RANBP2 RGPD8 MYO1C RGPD1 DNAJC18 APOB RGPD3 ASPM PKHD1 CCAR1 ATM ARHGEF4 PREX1 MED13 RGPD5 | 6.05e-05 | 1442 | 138 | 17 | 35575683 | |
| Pubmed | 6.63e-05 | 20 | 138 | 3 | 15340084 | ||
| Interaction | RGPD4 interactions | 8.55e-11 | 22 | 136 | 7 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 4.33e-10 | 27 | 136 | 7 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 2.74e-08 | 47 | 136 | 7 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 3.70e-08 | 49 | 136 | 7 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 6.74e-07 | 74 | 136 | 7 | int:RGPD8 | |
| Interaction | RGPD5 interactions | 3.95e-06 | 96 | 136 | 7 | int:RGPD5 | |
| Interaction | NPIPB6 interactions | 5.64e-06 | 18 | 136 | 4 | int:NPIPB6 | |
| Cytoband | 2q13 | 5.48e-05 | 68 | 138 | 4 | 2q13 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.22e-08 | 115 | 98 | 9 | 769 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.52e-04 | 66 | 98 | 4 | 722 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 6.00e-04 | 7 | 98 | 2 | 917 | |
| GeneFamily | Anoctamins | 1.27e-03 | 10 | 98 | 2 | 865 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 1.52e-03 | 42 | 98 | 3 | 602 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 2.37e-03 | 49 | 98 | 3 | 584 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 1.88e-08 | 33 | 138 | 6 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 9.92e-08 | 43 | 138 | 6 | MM3857 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | RGPD4 RGPD2 RANBP2 RGPD8 MYO10 RGPD1 MFSD6L SAMHD1 PARP14 ADGRG6 RMDN3 RGPD3 | 3.47e-06 | 435 | 138 | 12 | MM1221 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD4 RGPD2 RANBP2 MED30 RGPD8 RGPD1 SAMHD1 SBNO2 ZSWIM9 RGPD3 CCAR1 RGPD5 | 8.28e-06 | 474 | 138 | 12 | M40991 |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 1.10e-05 | 199 | 138 | 8 | M5254 | |
| Coexpression | MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN | 2.57e-05 | 224 | 138 | 8 | M38981 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL | 3.30e-05 | 232 | 138 | 8 | M45800 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_TREG_CELL | 5.80e-05 | 40 | 138 | 4 | M45776 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-07 | 186 | 138 | 8 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-07 | 188 | 138 | 8 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-07 | 190 | 138 | 8 | 2f54da2bee411f8868348a4c37034184b8f58a89 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.80e-07 | 140 | 138 | 7 | 8abbd5dc799943b49cd0045d0da405c3f3d0db6b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_ciliated|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.80e-07 | 140 | 138 | 7 | e4689232c473d239b07a7fbcaaa3414fbd9badea | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.09e-07 | 157 | 138 | 7 | 275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-07 | 162 | 138 | 7 | 75df7ff779a3b9159ba97d852da1f8df650b9ce5 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-CX3CR1+_CD8_Tmem|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-06 | 176 | 138 | 7 | 6b06da40eb97ea2db09f3a769494738b3e5fe3fa | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-06 | 177 | 138 | 7 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-06 | 184 | 138 | 7 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-06 | 192 | 138 | 7 | 285a9d332a1e07b94f222d4b518dd56928b9e075 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-06 | 193 | 138 | 7 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|World / Lineage, cell class and subclass | 2.68e-06 | 196 | 138 | 7 | 42a4d706382be33d552ece1d0598d073857a8d4e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-06 | 197 | 138 | 7 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.96e-06 | 199 | 138 | 7 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | ca5401b76ab014080914bf78042d368cf318effa | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1--L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 70c47d3bbe67d88c5b9dff99c33a603d25fa2ab0 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-CA1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.06e-06 | 200 | 138 | 7 | 40286010bd17cf9e34ecd5440953b072ebfae208 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.32e-06 | 153 | 138 | 6 | 7480522a47e367f8facc4f5d599fbaf0b5ad4007 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.30e-06 | 156 | 138 | 6 | 53ded973358e3e48054130131e959f0d1f4ef60f | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.64e-06 | 157 | 138 | 6 | f6210be2362d833c6d869ff921188bfc85dda11d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.64e-06 | 157 | 138 | 6 | 43a6b423fd70479822a564ff4225a1e4951ae5ed | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-05 | 165 | 138 | 6 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-05 | 166 | 138 | 6 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-05 | 166 | 138 | 6 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 1.42e-05 | 168 | 138 | 6 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 168 | 138 | 6 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 175 | 138 | 6 | 9a96794df049d8228fea57c1584c160191d36b56 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 175 | 138 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.97e-05 | 178 | 138 | 6 | f332c7a96844abecf05ca057480fbea9296688a2 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.09e-05 | 180 | 138 | 6 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.09e-05 | 180 | 138 | 6 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.09e-05 | 180 | 138 | 6 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-05 | 181 | 138 | 6 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.23e-05 | 182 | 138 | 6 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.23e-05 | 182 | 138 | 6 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.23e-05 | 182 | 138 | 6 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-05 | 183 | 138 | 6 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.37e-05 | 184 | 138 | 6 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 186 | 138 | 6 | 5d0cd07b6b51e8ce9e1da949f757dc4575ec5752 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.59e-05 | 187 | 138 | 6 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.59e-05 | 187 | 138 | 6 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.59e-05 | 187 | 138 | 6 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.59e-05 | 187 | 138 | 6 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-05 | 188 | 138 | 6 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.67e-05 | 188 | 138 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.67e-05 | 188 | 138 | 6 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 188 | 138 | 6 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.67e-05 | 188 | 138 | 6 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.67e-05 | 188 | 138 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 2.75e-05 | 189 | 138 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.75e-05 | 189 | 138 | 6 | 9da012fdfa9a8d488cab710a463a1d70e89f990c | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8|blood / Manually curated celltypes from each tissue | 2.84e-05 | 190 | 138 | 6 | 5dca8654964c41580fa3b094579fe7cb296d406f | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 190 | 138 | 6 | 6c6d3259e23ec90c08756f500ae8a7aff8b8a5b3 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-05 | 190 | 138 | 6 | d87b9e9ca863270a9c7f61674271a6440c97d1f4 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-Treg|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.84e-05 | 190 | 138 | 6 | fe6fecdf2123f3a4fb20e7535472d562b1a74fb4 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.92e-05 | 191 | 138 | 6 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 191 | 138 | 6 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.01e-05 | 192 | 138 | 6 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-05 | 192 | 138 | 6 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.19e-05 | 194 | 138 | 6 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-05 | 194 | 138 | 6 | 4dfc890bacf133cfb6ec7c8b73f084f2491cf78e | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.28e-05 | 195 | 138 | 6 | 90136f65e3e72cf2b2e0a13b48a7c9d60628b396 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.28e-05 | 195 | 138 | 6 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-05 | 196 | 138 | 6 | cf7f384c1771274e766bab03ecc3dfbd13f2df60 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-05 | 197 | 138 | 6 | 2e3d64648a1e4f01b9256a96b94b8a640ee1824c | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|lymphoid / Lineage, cell class and subclass | 3.47e-05 | 197 | 138 | 6 | 73d5dcf076caae60ea32258b4e9dcac8979a661e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-05 | 197 | 138 | 6 | 0523aec9713ae21e6b879aa98e07fa2576610d5f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-05 | 197 | 138 | 6 | d95565652ca318a2298d6918d54ba6367e9560f4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-05 | 197 | 138 | 6 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 198 | 138 | 6 | 96883ad8e189a46ed5b7eaafc0543e53682d26ed | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|T_cell / Lineage, cell class and subclass | 3.57e-05 | 198 | 138 | 6 | 6773c6043ef4a3d9e9700330b6386431ee66abdc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-05 | 199 | 138 | 6 | 04adf46975aa4194ea40c7480f8a517def5d929c | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.67e-05 | 199 | 138 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Caecum-(1)_T_cell-(16)_Tfh|Caecum / shred on region, Cell_type, and subtype | 3.67e-05 | 199 | 138 | 6 | d07d77ae426dd1164d80d7031f14befa0369d3e5 | |
| ToppCell | Caecum-T_cell-Tfh|Caecum / Region, Cell class and subclass | 3.67e-05 | 199 | 138 | 6 | fb40f37d842f170ed101dfa3bffdb8f3b2c94f19 | |
| ToppCell | (1)_T_cell-(16)_Tfh|(1)_T_cell / shred on Cell_type and subtype | 3.78e-05 | 200 | 138 | 6 | 3b28137e8e69b98fde9f6ab8320cb4d1c3543ef9 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.78e-05 | 200 | 138 | 6 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | VE-CD4-CD8_2|VE / Condition, Cell_class and T cell subcluster | 3.92e-05 | 122 | 138 | 5 | 6745035feaf807b6a6b9537ac9d5ee0e000196eb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.31e-05 | 130 | 138 | 5 | c63f402d6ab71c2fcef12174b3139e55a727266c | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.35e-05 | 143 | 138 | 5 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.26e-04 | 156 | 138 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 158 | 138 | 5 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-04 | 161 | 138 | 5 | 46b5d80d2d521fb69752aba4c10383e715a32002 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-04 | 161 | 138 | 5 | 2165897924c790fec43502283f1df221c56c1e9f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.50e-04 | 162 | 138 | 5 | 19395bdb282b4a2d88cd33191af12c24a88c3d16 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.50e-04 | 162 | 138 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 162 | 138 | 5 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | normal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.54e-04 | 163 | 138 | 5 | 43887e7687fc6367efac0c1f56a9534b06f47b7f | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 164 | 138 | 5 | 15d52666e5150e7c34b1f641a937fb2d5e8aaf8a | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 164 | 138 | 5 | d622f0d8d8bad48dfdf160ec63c545df192637a9 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 165 | 138 | 5 | e32697321cef424c2ad4e11ee9da3e510d5ce505 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 165 | 138 | 5 | 0fbdd043e11aa8dbff4cd3a4da1b2feb49878a09 | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.68e-04 | 166 | 138 | 5 | f8f8423423d72f0ea0266b59126abb27beb23094 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-04 | 168 | 138 | 5 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-intermediate_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.78e-04 | 168 | 138 | 5 | 00cff4698db14e03ca1d1b409e5ed1ad23b12615 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-04 | 168 | 138 | 5 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 168 | 138 | 5 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 169 | 138 | 5 | 2d3618f78484bd3508b7bdae3a0d0183cdae5057 | |
| Disease | triglyceride change measurement, low density lipoprotein cholesterol measurement | 1.99e-05 | 2 | 132 | 2 | EFO_0004611, EFO_0007681 | |
| Disease | Coronary heart disease | 1.65e-04 | 24 | 132 | 3 | C0010068 | |
| Disease | adrenoleukodystrophy (implicated_via_orthology) | 4.11e-04 | 7 | 132 | 2 | DOID:10588 (implicated_via_orthology) | |
| Disease | Autistic behavior | 5.46e-04 | 8 | 132 | 2 | C0856975 | |
| Disease | interleukin 2 measurement | 8.24e-04 | 41 | 132 | 3 | EFO_0008331 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.00e-03 | 169 | 132 | 5 | DOID:3908 (is_marker_for) | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.06e-03 | 11 | 132 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | Celiac Disease | 1.23e-03 | 47 | 132 | 3 | C0007570 | |
| Disease | cannabis dependence measurement | 1.31e-03 | 48 | 132 | 3 | EFO_0008457 | |
| Disease | alcohol and nicotine codependence | 1.50e-03 | 13 | 132 | 2 | EFO_0004776 | |
| Disease | infant head circumference | 2.01e-03 | 15 | 132 | 2 | EFO_0004577 | |
| Disease | smoking behavior, BMI-adjusted waist circumference | 2.24e-03 | 122 | 132 | 4 | EFO_0004318, EFO_0007789 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 2.29e-03 | 16 | 132 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | lymphocyte count | SH3TC2 MED30 MINK1 SAMHD1 ITGA4 PREX2 SBNO2 NUFIP1 DIP2A ATM PREX1 IL7R AGAP1 SMG6 RBM17 | 2.35e-03 | 1464 | 132 | 15 | EFO_0004587 |
| Disease | renovascular hypertension (biomarker_via_orthology) | 3.23e-03 | 19 | 132 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 3.23e-03 | 19 | 132 | 2 | C2936783 | |
| Disease | hemifacial microsomia | 3.23e-03 | 19 | 132 | 2 | MONDO_0015398 | |
| Disease | Sclerocystic Ovaries | 4.06e-03 | 144 | 132 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 4.06e-03 | 144 | 132 | 4 | C0032460 | |
| Disease | otitis media (implicated_via_orthology) | 4.33e-03 | 22 | 132 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 4.41e-03 | 702 | 132 | 9 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKTFRHLLLCQYRNI | 461 | P08173 | |
| YYEACRKAAKSLIKL | 86 | Q5FVE4 | |
| KKLRVFVYRNSLCIE | 461 | Q15582 | |
| IAADCKRVTVLKYFL | 1121 | Q86US8 | |
| LKRIECYKVTYRPLD | 191 | O60825 | |
| LVIFYCYIRKRCLKL | 126 | Q6UW88 | |
| KRKAISRELYEYCIK | 66 | P41223 | |
| KEILRLGFKSCLYYR | 576 | Q8NHU2 | |
| YREEKRRCEYLHQKL | 366 | Q9HB65 | |
| RKLSNDLKRCTYYET | 196 | Q9UPQ3 | |
| FYNRKDFRIKQCTRV | 366 | P12821 | |
| NKVVLRESCFYRKLT | 966 | Q8IX12 | |
| IVYAQRRLKKIGIFC | 466 | Q9H7F0 | |
| KVFNTYIRRYILKFC | 961 | Q86SQ4 | |
| VFNTYIRKYILKFCI | 726 | Q8IZP9 | |
| AKGRRETYLCYVVKR | 21 | Q9GZX7 | |
| IYRCQKAFVKALEQR | 336 | Q9NR80 | |
| EAQRLSLRFAKCTKY | 146 | A6QL63 | |
| YKVLTRNIEYIAKCL | 421 | Q9UGM1 | |
| FRKYILQLFKTCRGL | 311 | P51679 | |
| IKSFCYRRLQYLSSK | 371 | Q01433 | |
| KCRIDYILVYRKSNP | 116 | Q32M45 | |
| CSRIAIKKYLRAGYD | 466 | Q96NY7 | |
| RTNIKCDRKVSLYGY | 271 | Q14692 | |
| CYRSKKIAAQKREEY | 1711 | Q8IZT6 | |
| YLNIKGRIIKIYCAD | 1731 | P59510 | |
| CERATQRIAFKKKLY | 651 | Q709F0 | |
| LATFYRENRLKKLCQ | 466 | O95199 | |
| ECKNYLRKTRDYLIK | 706 | P49792 | |
| VEPKFVKRLRYCEYL | 441 | Q9H714 | |
| ECRNYLTKTRDYLIK | 706 | Q99666 | |
| ECRNYLTKTRDYLIK | 706 | O14715 | |
| KRQLEDDCYYINRRK | 106 | P0C860 | |
| ECRNLEKLYLYFNKI | 96 | Q6ZRR7 | |
| CKERIRDVVYFQARL | 706 | Q9UJX4 | |
| IKLYVRCVFITDDFR | 66 | Q58FF3 | |
| RFRELKLQHKEYLCV | 386 | Q92731 | |
| LIQAYKVFREEKYLC | 286 | O43813 | |
| ELKIKYRQSYIFRLC | 116 | Q6ZMV7 | |
| CIIKRYCEKRFVSKY | 31 | Q9NZQ0 | |
| KEYLADRRYCVTQLL | 521 | Q17RB8 | |
| YLCTNKREQKQFFER | 1136 | Q8IVV2 | |
| SFKKYRCRIRVIDTF | 381 | Q3V5L5 | |
| CAFLAKSYRKRRALL | 66 | Q8IWD5 | |
| RRYLSFRVIKVNKEC | 1931 | Q96RV3 | |
| KILLRKFCQIRYHTN | 351 | P43115 | |
| KKQLEDDCYYINRRK | 181 | Q8N5Y2 | |
| DDCYYINRRKRLVKL | 186 | Q8N5Y2 | |
| FLARKQYRKVLYCVV | 756 | Q9HD67 | |
| KCLNFRKLQEIYFIE | 81 | P16871 | |
| AYCLALQLYVRRRKK | 251 | Q13651 | |
| CVKRKQRYEVDYNLE | 706 | Q5XXA6 | |
| RRFQIAQYKCLVIKY | 41 | P04183 | |
| AQYKCLVIKYAKDTR | 46 | P04183 | |
| SVLFRKLRLVYDKCN | 86 | Q96HR3 | |
| KRELQVLYRGFKNEC | 61 | Q9NZI2 | |
| CLRRSIYKNKFELTY | 316 | Q9UG01 | |
| YIQYCRKFDIDIRLQ | 446 | O00750 | |
| DRKLVYCLKRNLRSY | 111 | P39877 | |
| VQLSLCLAEKYKYRS | 901 | Q460N5 | |
| EECKNYLRKTRGYLI | 706 | A6NKT7 | |
| LCKYIYAKDRTDRIR | 551 | Q99613 | |
| RLCKYIYAKDRTDRI | 551 | B5ME19 | |
| FRFLQKYIQKETECL | 61 | Q13315 | |
| CKLDFREIQIYKKLR | 3761 | P04114 | |
| SYVKLRDFVLVKLCQ | 281 | O14929 | |
| CVLFRKYGNFIDKLR | 6 | A4D1E9 | |
| VAKYCSKLRYLNARG | 371 | Q9UJT9 | |
| ISCYRQIEAKALKVR | 91 | Q8NBF6 | |
| AVKRVKQCKDYYEIL | 101 | Q9NXW2 | |
| YRVKQRKLDYKCFSE | 66 | A0A1W2PPF3 | |
| LFLYEKAIVFCKRRV | 726 | P10911 | |
| LRKYREKYCTFNDDI | 266 | P23368 | |
| IVRFLSKTDKRLLYC | 876 | P13612 | |
| LLGVQRIKKCRNYYE | 71 | Q9H819 | |
| RIKKCRNYYEILGVS | 76 | Q9H819 | |
| YDCIFKRRLDYDQKL | 56 | A4QMS7 | |
| SFERCLKTYAIKRAA | 931 | Q05BV3 | |
| VCFYKARAALVKSRD | 596 | Q14689 | |
| ALREKVYASLEAYCK | 391 | P19793 | |
| EKLEIYKPTARYCIR | 356 | B1AKI9 | |
| YYFRVTCKEEKVLRN | 521 | P43246 | |
| ARKFFTLYKLCEEQL | 2131 | Q8TE73 | |
| EECKNYLRKTRDYLI | 696 | P0DJD0 | |
| RDGKTYCKRDYVRLF | 71 | Q96A47 | |
| IRKYKKRFNSEILCA | 1011 | Q8N4C8 | |
| LRVFYYLVQDLKCLV | 121 | Q96A72 | |
| AYRCFKERRVTKAYL | 86 | Q9UJJ7 | |
| NKERSRRYAIFCLFK | 121 | Q8IZC4 | |
| RILKKCYRGRFQLIE | 121 | Q9BQQ7 | |
| RVQCRQVFLKYILDY | 2261 | O75691 | |
| YCLLKILKQYQTLRE | 1241 | O14607 | |
| EECKNYLRKTRGYLI | 706 | Q7Z3J3 | |
| RVYISKCYRELGKNS | 421 | Q96TC7 | |
| RVYCKKVDRKSLYAA | 551 | Q9Y3Z3 | |
| NVKFKVRCSRYLYTL | 31 | P63173 | |
| CKNYLRKTRDYLIKI | 706 | P0DJD1 | |
| NYTCELKYEGKLVRR | 211 | Q9NP60 | |
| ELELYRKQCNARKKY | 156 | Q8WW32 | |
| SFGKFDLYRKRCQII | 791 | Q96CC6 | |
| ERKRQLKKQYYFDCT | 261 | Q8NB12 | |
| FFLFDNLLVYCKRKS | 291 | Q8TCU6 | |
| FVNKSYLLDKRACRQ | 256 | Q6PI26 | |
| YEYLELRFNKCVRLC | 116 | Q8N695 | |
| QRFFKYLCIAAKVRR | 541 | Q9Y2G9 | |
| KVYYRLGRLTFCQLK | 1211 | Q8TF17 | |
| NLRLKNFKVYSCRDF | 2411 | P08F94 | |
| FSKLKLYAQVCRYDL | 1446 | Q9UHV7 | |
| FIYCLRNREVKEALK | 286 | O95007 | |
| IFARKDQCRYIRDIA | 326 | Q01968 | |
| YSEEYLRNLLCRKKL | 246 | Q9BX79 | |
| KLCFRVRLTKYLYEE | 151 | P28288 | |
| DVCDKVFIRKRYLAR | 246 | Q8N782 | |
| CLLIYTVKIRRFNKA | 186 | Q8IY95 | |
| LKYSYVRLVCKDVRA | 71 | Q86XI8 | |
| CRYRVKNLLRNYRKA | 376 | P17040 | |
| LQCVRYIIKKDFFGL | 471 | Q9UHK0 | |
| VYRCTPKNLDYKRDL | 151 | Q9NYP9 | |
| EQVKKRRYDLFTQCF | 1056 | Q8NDV3 | |
| YLKRVCKLYSEQRAI | 141 | Q9P2W9 | |
| FRFKVLILAYAVCRL | 106 | O95772 | |
| VVKACFYNLDKFRVL | 381 | Q96I25 | |
| DNDIRFICKYKRNIF | 2036 | Q9HCK1 | |
| DTYIKERKLCAYPRL | 156 | Q9Y6I9 | |
| ELQIREKNERYYCVL | 216 | Q8IWV7 | |
| VKKLRYYARFIVVCL | 176 | Q8N9R8 | |
| FLFDNLLVYCKRKHR | 266 | Q70Z35 | |
| AVRYERKKRNICYDP | 316 | Q495X7 | |
| LQICELEKRFHRQKY | 211 | P31314 | |
| IIYTRDKLYKREECS | 246 | Q96N22 | |
| NCKSKRAVRDYLFRV | 2596 | O43149 | |
| FQKVTLRRYRKCGYE | 31 | Q03924 | |
| KFCVRYFRSKNLLIE | 111 | Q96JM2 | |
| ANLYGYIRCKVRSRK | 166 | Q9NYZ1 | |
| QFCDKSFIRLSYLKR | 141 | Q2M1K9 | |
| KECGKLFNRIAYLAR | 246 | Q5HY98 | |
| PKYERVKELCQQARY | 436 | Q8IWU6 | |
| LLRFNFDFVKCERYK | 246 | Q9NVE5 | |
| LVNYYRGADKLCRKA | 61 | Q8NG68 | |
| YCRAARQLVEKEKYS | 2406 | Q68DK2 | |
| YQKCYSIEQPLRRDK | 96 | P52741 | |
| VQYLDRAEKLKDYLR | 61 | Q9UN37 | |
| CYDLLVRKKRLIVLF | 241 | Q9P055 | |
| RKYEAFLQRYKSLCP | 666 | O00159 |